Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more
Market Cap & Net Worth: Sysmex Corporation (SSMXF)
Sysmex Corporation (PINK:SSMXF) has a market capitalization of $12.05 Billion ($12.05 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #1916 globally and #1387 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sysmex Corporation's stock price $19.34 by its total outstanding shares 623180031 (623.18 Million).
Sysmex Corporation Market Cap History: 2015 to 2025
Sysmex Corporation's market capitalization history from 2015 to 2025. Data shows growth from $11.79 Billion to $12.05 Billion (1.68% CAGR).
Sysmex Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sysmex Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Sysmex Corporation's market cap is 0.02 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.22x
Sysmex Corporation's market cap is 0.22 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.79 Billion | $253.16 Billion | $39.28 Billion | 0.04x | 0.27x |
| 2017 | $14.49 Billion | $249.90 Billion | $40.64 Billion | 0.06x | 0.36x |
| 2018 | $9.34 Billion | $281.94 Billion | $39.22 Billion | 0.03x | 0.24x |
| 2019 | $13.46 Billion | $293.51 Billion | $41.22 Billion | 0.05x | 0.33x |
| 2020 | $24.32 Billion | $301.98 Billion | $34.88 Billion | 0.08x | 0.70x |
| 2021 | $26.88 Billion | $305.07 Billion | $31.90 Billion | 0.09x | 0.84x |
| 2022 | $11.86 Billion | $363.78 Billion | $44.09 Billion | 0.03x | 0.27x |
| 2023 | $10.88 Billion | $410.50 Billion | $45.78 Billion | 0.03x | 0.24x |
| 2024 | $12.54 Billion | $461.51 Billion | $49.64 Billion | 0.03x | 0.25x |
| 2025 | $12.05 Billion | $508.64 Billion | $53.67 Billion | 0.02x | 0.22x |
Competitor Companies of SSMXF by Market Capitalization
Companies near Sysmex Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to Sysmex Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Sysmex Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Sysmex Corporation's market cap moved from $11.79 Billion to $ 12.05 Billion, with a yearly change of 1.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $12.05 Billion | -3.94% |
| 2024 | $12.54 Billion | +15.31% |
| 2023 | $10.88 Billion | -8.27% |
| 2022 | $11.86 Billion | -55.88% |
| 2021 | $26.88 Billion | +10.54% |
| 2020 | $24.32 Billion | +80.72% |
| 2019 | $13.46 Billion | +44.08% |
| 2018 | $9.34 Billion | -35.54% |
| 2017 | $14.49 Billion | +34.24% |
| 2016 | $10.79 Billion | -8.43% |
| 2015 | $11.79 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sysmex Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.05 Billion USD |
| MoneyControl | $12.05 Billion USD |
| MarketWatch | $12.05 Billion USD |
| marketcap.company | $12.05 Billion USD |
| Reuters | $12.05 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.